The PSA Total Test measures the level of prostate-specific antigen in the blood, helping to screen for prostate cancer, monitor existing conditions, and evaluate treatment effectiveness.

Avoid vigorous activities and sexual activity for 48 hours before the test. Inform your doctor about any medications you are taking. No fasting is required.

Elevated PSA levels may suggest prostate inflammation, benign prostatic hyperplasia (BPH), or prostate cancer. Further tests may be required for a definitive diagnosis.

Results are typically available within 24 to 48 hours after the blood sample is collected.

Discuss the results with your healthcare provider to determine the next steps, which may include additional tests or a referral to a specialist for further evaluation.

CRRT is a medical therapy used in intensive care units to manage patients with acute kidney injury (AKI) or severe kidney dysfunction. It involves the continuous removal of waste products and excess fluids from the blood.

CRRT is used when a patient’s kidneys are unable to adequately filter waste and excess fluids from the blood, leading to dangerous levels of toxins and fluid overload.

CRRT differs from hemodialysis in that it is slower and performed continuously over 24 hours or longer periods. Hemodialysis, on the other hand, is intermittent and typically lasts for a few hours.

Yes, CRRT can be used cautiously in patients with heart failure to manage fluid overload and electrolyte imbalances, with careful monitoring of hemodynamic status.

CRRT provides gentler and more gradual fluid and solute removal, making it suitable for hemodynamically unstable patients who cannot tolerate the rapid changes associated with conventional hemodialysis.

Types include flexible ureteroscopy for lower ureter and kidney issues, and rigid ureteroscopy for upper ureter conditions.